More than half of screenings in 2012 yield suspicious findings, prompting early skin cancer treatment
New York, NY (November 5, 2012) – The Skin Cancer Foundation’s annual Road to Healthy Skin Tour, presented by AVEENO® and Rite Aid, has wrapped up another year on the road, after bringing free skin cancer screenings and skin cancer information to 3,051 people across the country. In 2012, the fifth year of the Tour, volunteer dermatologists detected a record-breaking 1,676 suspected precancers and cancers this year, including 56 suspected cases of melanoma, the deadliest form of skin cancer. The 5-year survival rate for patients whose melanoma is detected early, before the tumor has penetrated the skin, is about 98 percent. The survival rate declines significantly if the disease has the chance to metastasize (spread).
“The alarming number of suspected precancers and cancers found during this year’s Tour speaks to the need for public awareness of skin cancer prevention and early detection,” says Perry Robins, MD, President of The Skin Cancer Foundation. “Since 2008, our volunteer dermatologists have provided free screenings to more than 16,000 people, and we’re eager to offer more of these potentially lifesaving screenings next year.”
This year’s Tour made 78 stops throughout 22 states over the course of 27 weeks. An outpouring of generosity and community support was integral to this year’s success. 131 dermatologists donated their time to the cause, performing the screenings in the Tour’s customized RV equipped with two private exam rooms. Rite Aid employees volunteered at many of their respective Tour stops, supplying tents for shade and water to people waiting in line. Some participants reported tracking the Tour route on The Skin Cancer Foundation’s website and traveling several hours to receive screenings. This year’s route spanned approximately 22,000 miles.
The Skin Cancer Foundation recommends that everyone over the age of 18 see a dermatologist annually for a full-body skin-exam. The Foundation also recommends that everyone examine their skin from head-to-toe at least once a month, looking for any new or changing lesions that might be cancerous or precancerous. A yearly skin exam performed by a physician is important, but it’s just as important to see a professional whenever a mole changes or grows.
The 2012 Road to Healthy Skin Tour was made possible by the generous support of presenting sponsors AVEENO® and Rite Aid. Additional support was provided by Columbia Sportswear Company, FITNESS magazine and LEO Pharma, Inc. For more information about the Tour and other interactive features, visit www.skincancer.org/tour.
Editor’s Note: Hi-res photos from The Road to Healthy Skin Tour are available upon request.
Carla Barry-Austin (212-725-5641; firstname.lastname@example.org)
Becky Wiley (646-583-7988; email@example.com)
About The Skin Cancer Foundation
The Skin Cancer Foundation is the only global organization solely devoted to the prevention, early detection and treatment of skin cancer. The mission of the Foundation is to decrease the incidence of skin cancer through public and professional education and research. For more information, visit www.SkinCancer.org.
The AVEENO® Brand is one of the brands of Johnson & Johnson Consumer Products Company division of Johnson & Johnson Consumer Companies, Inc. The AVEENO® Brand, a leader in ACTIVE NATURALS® technologies, uses the best of nature to deliver scientifically proven results. Most trusted by dermatologists for its natural ingredients and recommended for more than 60 years, the Brand is committed to developing breakthrough product formulations with new and existing natural ingredients that deliver clinically proven, effective beauty care products. The AVEENO® line includes products for face, body, baby, hair and sun protection. For more information about the AVEENO® Brand and its product offerings, visit www.aveeno.com or 'Like' us at www.facebook.com/aveeno.
Rite Aid Corporation (NYSE: RAD) is one of the nation’s leading drugstore chains with more than 4,600 stores in 31 states and the District of Columbia and fiscal 2012 annual revenues of $26.1 billion. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at www.riteaid.com.
Columbia Sportswear Company
Founded in 1938 in Portland, Oregon, Columbia Sportswear Company is a global leader in the design, sourcing, marketing and distribution of active outdoor apparel and footwear. As one of the largest outerwear manufacturers in the world and a leading seller of skiwear in the United States, the Company has developed an international reputation for quality, performance, functionality and value. The Company manages a portfolio of outdoor brands including Columbia Sportswear, Montrail, Mountain Hardwear, Pacific Trail, and Sorel. To learn more about Columbia, please visit the Company's website at www.columbia.com.
Launched in 1992, FITNESS magazine is celebrating twenty years as a leading source for all the latest news on health, nutrition and exercise. FITNESS motivates women to move—for fun, for health, for life. With workouts and diet plans that get results, plus inspiring beauty and health tips, FITNESS empowers women to be fierce about reaching for and achieving body success, however they define it. FITNESS is published 10 times a year by Meredith Corporation [NYSE: MDP], with a rate base of 1.5 million and an audience of 7.3 million readers. For more information, please visit www.fitnessmagazine.com.
LEO Pharma Inc.
LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more than 100 years of history as an independent, research-based specialty pharmaceutical company. LEO Pharma A/S, makers of the Taclonex® and newly released Picato® brand of products, is wholly owned by the LEO Foundation. The company is developing a number of new products, in their quest to helping people achieve healthy skin. To learn more about LEO Pharma Inc., visit www.leo-pharma.us.